Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 2
1994 1
1995 1
1996 1
1997 2
1998 1
1999 3
2000 1
2001 4
2002 3
2003 4
2004 6
2005 6
2006 12
2007 2
2008 3
2009 2
2010 2
2011 4
2012 6
2013 3
2014 3
2015 2
2016 2
2020 1
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 11599334

70 results
Results by year
Filters applied: . Clear all
Page 1
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.
Kalant H. Kalant H. CMAJ. 2001 Oct 2;165(7):917-28. CMAJ. 2001. PMID: 11599334 Free PMC article. Review.
MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
Parrott AC. Parrott AC. J Psychopharmacol. 2006 Mar;20(2):147-63. doi: 10.1177/0269881106063268. J Psychopharmacol. 2006. PMID: 16510474 Review.
[Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity].
Giroud C, Augsburger M, Sadeghipour F, Varesio E, Veuthey JL, Rivier L. Giroud C, et al. Praxis (Bern 1994). 1997 Mar 25;86(13):510-23. Praxis (Bern 1994). 1997. PMID: 9157497 Review. French.
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
Parrott AC. Parrott AC. J Psychopharmacol. 2005 Jan;19(1):71-83. doi: 10.1177/0269881105048900. J Psychopharmacol. 2005. PMID: 15671132 Review.
Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues.
Lyvers M. Lyvers M. Drug Alcohol Rev. 2006 May;25(3):269-76. doi: 10.1080/09595230600657758. Drug Alcohol Rev. 2006. PMID: 16753651 Review.
MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves.
Parrott AC. Parrott AC. Neuropsychobiology. 2004;50(4):329-35. doi: 10.1159/000080961. Neuropsychobiology. 2004. PMID: 15539865 Review.
MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
Parrott AC. Parrott AC. Neurosci Biobehav Rev. 2013 Sep;37(8):1466-84. doi: 10.1016/j.neubiorev.2013.04.016. Epub 2013 May 6. Neurosci Biobehav Rev. 2013. PMID: 23660456 Review.
Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.
Gouzoulis-Mayfrank E, Daumann J. Gouzoulis-Mayfrank E, et al. Dialogues Clin Neurosci. 2009;11(3):305-17. Dialogues Clin Neurosci. 2009. PMID: 19877498 Free PMC article. Review.
Event-related potentials (ERPs) in ecstasy (MDMA) users during a visual oddball task.
Mejias S, Rossignol M, Debatisse D, Streel E, Servais L, Guérit JM, Philippot P, Campanella S. Mejias S, et al. Biol Psychol. 2005 Jul;69(3):333-52. doi: 10.1016/j.biopsycho.2004.11.010. Biol Psychol. 2005. PMID: 15925034
The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA).
Freudenmann RW, Spitzer M. Freudenmann RW, et al. CNS Drug Rev. 2004 Summer;10(2):89-116. doi: 10.1111/j.1527-3458.2004.tb00007.x. CNS Drug Rev. 2004. PMID: 15179441 Free PMC article. Review.
70 results
Jump to page
Feedback